Latest digestive disease Stories

ORLANDO, Fla., May 21, 2013 /PRNewswire-USNewswire/ -- Research presented today at Digestive Disease Week® (DDW) explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease. While coffee consumption recently has been associated with reduced risk of fibrosis, a new study found that even a few more cups of java each month also correlate with lower risk for a particular autoimmune liver disease. Researchers at the Mayo Clinic,...

OAKLAND, Calif., Dec. 13, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2013 Innovator Awards Program for Inflammatory Bowel Disease (IBD). The Program supports "out-of-the-box" innovative research projects that are potentially transformative to the Foundation's efforts to diagnose, treat and/or cure IBD. The Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research...

PRINCETON, N.J., Sept. 13, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the company), a development stage biopharmaceutical company announced today that the US Patent Office granted patent 8,263,582 entitled "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of beclomethasone dipropionate (BDP) in orally administered dosage forms that act...

OAKLAND, Calif., Aug. 24, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation (KRF) announced today the recipients of its 2012 Innovator Awards and its 2012 Breakthrough Awards for Inflammatory Bowel Disease (IBD) research. Innovator Award recipients will each receive a $100,000 grant to support their respective innovative research projects. Breakthrough Awards are extended to existing KRF Innovator Award recipients, whose projects have demonstrated significant promise...

GOTHENBURG, Sweden, July 24, 2012 /PRNewswire/ -- Albireo AB (Gothenburg, Sweden; "Albireo"), a biopharmaceutical company specializing in gastroenterology, today announced that the European Medicines Agency Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on an application for orphan medicinal product status for the company's lead hepatology candidate, A4250, for the treatment of: - Primary Biliary Cirrhosis (PBC) -...

Fecal Transplants, Hepatitis C, Efficacy of Probiotics, Smoking's Impact on GI Health, Vitamin D in IBD Therapy, Adult IBS and Childhood Trauma Link Among Featured Science WASHINGTON, Oct. 31, 2011 /PRNewswire-USNewswire/ -- Many of the world's preeminent gastroenterologists have convened this week for the American College of Gastroenterology's (ACG) 76th Annual Scientific Meeting at the Gaylord National Hotel and Conference Center at the National Harbor to review the latest scientific...

Linking it to bacterial overgrowth, food poisoningCedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.One study provides further evidence that IBS is linked to an overgrowth of bacteria in the gut. In a separate study, a mathematical model reveals the disease's link to food poisoning and shows that military personnel are at a much higher...

Health outcomes explored at DDW 2011Research being presented at Digestive Disease Week® (DDW) shows that patients taking a blood thinner (clopidogrel) after having polyps removed during colonoscopy were at relatively low risk of bleeding. Another study shows that a new drug that acts as a hormone, teduglutide, increases intestinal absorption for individuals with short bowel syndrome, which may decrease dependence on intravenous fluid and nutritional support in this at-risk population. A...

Researchers at the Georgia Institute of Technology and Emory University have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. Delivering short strands of RNA into cells has become a popular research area because of its potential therapeutic applications, but how to deliver them into targeted cells in a living organism has been an obstacle.In the Oct. 10 advance online edition of the journal Nature...

SUNNYVALE, Calif., July 14 /PRNewswire/ -- BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal...